ArticleOPEN ACCESS

The Current State of Pharma and the FDA: Approval of a Dementia Drug as a Case in Point

American Journal of Medicine
DOI: 10.1016/j.amjmed.2021.06.014
1Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Cite

CITATION STYLE

APA

Eiser, A. R. (2021, December 1). The Current State of Pharma and the FDA: Approval of a Dementia Drug as a Case in Point. American Journal of Medicine. Elsevier Inc. https://doi.org/10.1016/j.amjmed.2021.06.014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free